Human Molecular Genetics, Vol 7, 913-918, Copyright © 1998 by Oxford University Press
M Holmberg, C Duyckaerts, A Durr, G Cancel, I Gourfinkel-An, P Damier, B Faucheux, Y Trottier, EC Hirsch, Y Agid and A Brice
Autosomal dominant cerebellar ataxia with progressive macular degeneration
is caused by a CAG/glutamine repeat expansion in the SCA7 gene/protein.
Neuronal intranuclear inclusions were detected in the brain of an early
onset SCA7 case with the 1C2 antibody directed against an expanded
polyglutamine domain. Nuclear inclusions were most frequent in the inferior
olivary complex, a site of severe neuronal loss in SCA7. They were also
observed in other brain regions, including the cerebral cortex, not
considered to be affected in the disease. Using confocal microscopy we
showed that some inclusions were ubiquitinated, but to varying degrees,
ranging from <1% in the cerebral cortex to 60% in the inferior olive. In
addition, we also observed cytoplasmic staining using the 1C2 antibody,
particularly in the supramarginal gyrus, the hippocampus, the thalamus, the
lateral geniculate body and the pontine nuclei. These data confirm that the
presence of intranuclear inclusions in neurons is a common characteristic
of disorders caused by CAG/polyglutamine expansions, but unlike what has
been reported for Huntington's disease, SCA1 and SCA3/MJD, in SCA7 the
inclusions were not restricted to the sites of severe neuronal loss.
ARTICLES
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions
INSERM U289, Laboratoire de Neuropathologie R.Escourolle, Federation de Neurologie, 47 boulevard de l'Hopital, 75651 Paris Cedex 13, France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Latouche, C. Lasbleiz, E. Martin, V. Monnier, T. Debeir, A. Mouatt-Prigent, M.-P. Muriel, L. Morel, M. Ruberg, A. Brice, et al. A Conditional Pan-Neuronal Drosophila Model of Spinocerebellar Ataxia 7 with a Reversible Adult Phenotype Suitable for Identifying Modifier Genes J. Neurosci., March 7, 2007; 27(10): 2483 - 2492. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Brignull, F. E. Moore, S. J. Tang, and R. I. Morimoto Polyglutamine proteins at the pathogenic threshold display neuron-specific aggregation in a pan-neuronal Caenorhabditis elegans model. J. Neurosci., July 19, 2006; 26(29): 7597 - 7606. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ellisdon, B. Thomas, and S. P. Bottomley The Two-stage Pathway of Ataxin-3 Fibrillogenesis Involves a Polyglutamine-independent Step J. Biol. Chem., June 23, 2006; 281(25): 16888 - 16896. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Faux, S. P. Bottomley, A. M. Lesk, J. A. Irving, J. R. Morrison, M. G. de la Banda, and J. C. Whisstock Functional insights from the distribution and role of homopeptide repeat-containing proteins Genome Res., April 1, 2005; 15(4): 537 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Burnett and R. N. Pittman The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation PNAS, March 22, 2005; 102(12): 4330 - 4335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. M. Chow, A. M. Ellisdon, L. D. Cabrita, and S. P. Bottomley Polyglutamine Expansion in Ataxin-3 Does Not Affect Protein Stability: IMPLICATIONS FOR MISFOLDING AND DISEASE J. Biol. Chem., November 12, 2004; 279(46): 47643 - 47651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Everett and N. W. Wood Trinucleotide repeats and neurodegenerative disease Brain, November 1, 2004; 127(11): 2385 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
O Y Bang, P H Lee, S Y Kim, H J Kim, and K Huh Pontine atrophy precedes cerebellar degeneration in spinocerebellar ataxia 7: MRI-based volumetric analysis J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1452 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michalik and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet., October 15, 2003; 12(90002): R173 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Josephs, J. L. Holton, M. N. Rossor, H. Braendgaard, T. Ozawa, N. C. Fox, R. C. Petersen, G. S. Pearl, M. Ganguly, P. Rosa, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain, October 1, 2003; 126(10): 2291 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.J. Cowan, M.I. Diamond, and W.J. Welch Polyglutamine protein aggregation and toxicity are linked to the cellular stress response Hum. Mol. Genet., June 15, 2003; 12(12): 1377 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Einum, A. M. Clark, J. J. Townsend, L. J. Ptacek, and Y.-H. Fu A Novel Central Nervous System-Enriched Spinocerebellar Ataxia Type 7 Gene Product Arch Neurol, January 1, 2003; 60(1): 97 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Walcott and D. E. Merry Ligand Promotes Intranuclear Inclusions in a Novel Cell Model of Spinal and Bulbar Muscular Atrophy J. Biol. Chem., December 20, 2002; 277(52): 50855 - 50859. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, J. R. Dunlap, R. B. Andrews, and R. Wetzel Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells Hum. Mol. Genet., November 1, 2002; 11(23): 2905 - 2917. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ishikawa, M. Yamada, K. Makino, I. Aida, J. Idezuka, T. Ikeuchi, Y. Soma, H. Takahashi, and S. Tsuji Dementia and Delirium in 4 Patients With Machado-Joseph Disease Arch Neurol, November 1, 2002; 59(11): 1804 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Greco, R. J. Hagerman, F. Tassone, A. E. Chudley, M. R. Del Bigio, S. Jacquemont, M. Leehey, and P. J. Hagerman Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers Brain, August 1, 2002; 125(8): 1760 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Takahashi, H. Fujigasaki, C. Zander, K. H. El Hachimi, G. Stevanin, A. Durr, A.-S. Lebre, G. Yvert, Y. Trottier, H. d. The, et al. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content Brain, July 1, 2002; 125(7): 1534 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Garden, R. T. Libby, Y.-H. Fu, Y. Kinoshita, J. Huang, D. E. Possin, A. C. Smith, R. A. Martinez, G. C. Fine, S. K. Grote, et al. Polyglutamine-Expanded Ataxin-7 Promotes Non-Cell-Autonomous Purkinje Cell Degeneration and Displays Proteolytic Cleavage in Ataxic Transgenic Mice J. Neurosci., June 15, 2002; 22(12): 4897 - 4905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Chuang, H. Zhou, M. Zhu, S.-H. Li, X.-J. Li, and C.-H. Sung Characterization of a Brain-enriched Chaperone, MRJ, That Inhibits Huntingtin Aggregation and Toxicity Independently J. Biol. Chem., May 24, 2002; 277(22): 19831 - 19838. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. de Almeida, C. A. Ross, D. Zala, P. Aebischer, and N. Deglon Lentiviral-Mediated Delivery of Mutant Huntingtin in the Striatum of Rats Induces a Selective Neuropathology Modulated by Polyglutamine Repeat Size, Huntingtin Expression Levels, and Protein Length J. Neurosci., May 1, 2002; 22(9): 3473 - 3483. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. McLaughlin and T. P. Dryja Ocular Findings in Spinocerebellar Ataxia 7 Arch Ophthalmol, May 1, 2002; 120(5): 655 - 659. [Full Text] [PDF] |
||||
![]() |
J. T. Pang, P. Giunti, S. Chamberlain, S. F. An, R. Vitaliani, T. Scaravilli, L. Martinian, N. W. Wood, F. Scaravilli, and O. Ansorge Neuronal intranuclear inclusions in SCA2: a genetic, morphological and immunohistochemical study of two cases Brain, March 1, 2002; 125(3): 656 - 663. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Welch and M. I. Diamond Glucocorticoid modulation of androgen receptor nuclear aggregation and cellular toxicity is associated with distinct forms of soluble expanded polyglutamine protein Hum. Mol. Genet., December 1, 2001; 10(26): 3063 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matilla, C. Gorbea, D. D. Einum, J. Townsend, A. Michalik, C. van Broeckhoven, C. C. Jensen, K. J. Murphy, L. J. Ptacek, and Y.-H. Fu Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex Hum. Mol. Genet., November 1, 2001; 10(24): 2821 - 2831. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada, T. Sato, T. Shimohata, S. Hayashi, S. Igarashi, S. Tsuji, and H. Takahashi Interaction between Neuronal Intranuclear Inclusions and Promyelocytic Leukemia Protein Nuclear and Coiled Bodies in CAG Repeat Diseases Am. J. Pathol., November 1, 2001; 159(5): 1785 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zander, J. Takahashi, K. H. El Hachimi, H. Fujigasaki, V. Albanese, A. S. Lebre, G. Stevanin, C. Duyckaerts, and A. Brice Similarities between spinocerebellar ataxia type 7 (SCA7) cell models and human brain: proteins recruited in inclusions and activation of caspase-3 Hum. Mol. Genet., October 1, 2001; 10(22): 2569 - 2579. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yvert, K. S. Lindenberg, D. Devys, D. Helmlinger, G. B. Landwehrmeyer, and J.-L. Mandel SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types Hum. Mol. Genet., August 1, 2001; 10(16): 1679 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-S. Lebre, L. Jamot, J. Takahashi, N. Spassky, C. Leprince, N. Ravise, C. Zander, H. Fujigasaki, P. Kussel-Andermann, C. Duyckaerts, et al. Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions Hum. Mol. Genet., May 1, 2001; 10(11): 1201 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Orr Beyond the Qs in the polyglutamine diseases Genes & Dev., April 15, 2001; 15(8): 925 - 932. [Full Text] |
||||
![]() |
S. Yue, H. G. Serra, H. Y. Zoghbi, and H. T. Orr The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract Hum. Mol. Genet., January 1, 2001; 10(1): 25 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abel, J. Walcott, J. Woods, J. Duda, and D. E. Merry Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice Hum. Mol. Genet., January 1, 2001; 10(2): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cancel, C. Duyckaerts, M. Holmberg, C. Zander, G. Yvert, A.-S. Lebre, M. Ruberg, B. Faucheux, Y. Agid, E. Hirsch, et al. Distribution of ataxin-7 in normal human brain and retina Brain, December 1, 2000; 123(12): 2519 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yvert, K. S. Lindenberg, S. Picaud, G. B. Landwehrmeyer, J.-A. Sahel, and J.-L. Mandel Expanded polyglutamines induce neurodegeneration and trans-neuronal alterations in cerebellum and retina of SCA7 transgenic mice Hum. Mol. Genet., October 1, 2000; 9(17): 2491 - 2506. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Carmichael, J. Chatellier, A. Woolfson, C. Milstein, A. R. Fersht, and D. C. Rubinsztein Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease PNAS, July 30, 2000; (2000) 170280697. [Abstract] [Full Text] |
||||
![]() |
S. Hayes, G. Turecki, K. Brisebois, I. Lopes-Cendes, C. Gaspar, O. Riess, L. P.W. Ranum, S.-M. Pulst, and G. A. Rouleau CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2) Hum. Mol. Genet., July 22, 2000; 9(12): 1753 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Turmaine, A. Raza, A. Mahal, L. Mangiarini, G. P. Bates, and S. W. Davies Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease PNAS, June 23, 2000; (2000) 110078997. [Abstract] [Full Text] |
||||
![]() |
H. Shibata, D. P. Huynh, and S.-M. Pulst A novel protein with RNA-binding motifs interacts with ataxin-2 Hum. Mol. Genet., May 22, 2000; 9(9): 1303 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Cummings and H. Y. Zoghbi Fourteen and counting: unraveling trinucleotide repeat diseases Hum. Mol. Genet., April 1, 2000; 9(6): 909 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wyttenbach, J. Carmichael, J. Swartz, R. A. Furlong, Y. Narain, J. Rankin, and D. C. Rubinsztein Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease PNAS, March 14, 2000; 97(6): 2898 - 2903. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Senut, S. T. Suhr, B. Kaspar, and F. H. Gage Intraneuronal Aggregate Formation and Cell Death after Viral Expression of Expanded Polyglutamine Tracts in the Adult Rat Brain J. Neurosci., January 1, 2000; 20(1): 219 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Kaytor and S. T. Warren Aberrant Protein Deposition and Neurological Disease J. Biol. Chem., December 31, 1999; 274(53): 37507 - 37510. [Full Text] [PDF] |
||||
![]() |
M. D. Kaytor, L. A. Duvick, P. J. Skinner, M. D. Koob, L. P. W. Ranum, and H. T. Orr Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7 Hum. Mol. Genet., September 1, 1999; 8(9): 1657 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ishikawa, H. Fujigasaki, H. Saegusa, K. Ohwada, T. Fujita, H. Iwamoto, Y. Komatsuzaki, S. Toru, H. Toriyama, M. Watanabe, et al. Abundant expression and cytoplasmic aggregations of {alpha}1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6 Hum. Mol. Genet., July 1, 1999; 8(7): 1185 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, S.-H. Li, A. L. Cheng, L. Mangiarini, G. P. Bates, and X.-J. Li Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice Hum. Mol. Genet., July 1, 1999; 8(7): 1227 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Li, A. L. Cheng, H. Li, and X.-J. Li Cellular Defects and Altered Gene Expression in PC12 Cells Stably Expressing Mutant Huntingtin J. Neurosci., July 1, 1999; 19(13): 5159 - 5172. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Scherzinger, A. Sittler, K. Schweiger, V. Heiser, R. Lurz, R. Hasenbank, G. P. Bates, H. Lehrach, and E. E. Wanker Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology PNAS, April 13, 1999; 96(8): 4604 - 4609. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-A. Gutekunst, S.-H. Li, H. Yi, J. S. Mulroy, S. Kuemmerle, R. Jones, D. Rye, R. J. Ferrante, S. M. Hersch, and X.-J. Li Nuclear and Neuropil Aggregates in Huntington's Disease: Relationship to Neuropathology J. Neurosci., April 1, 1999; 19(7): 2522 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
D C Rubinsztein, A Wyttenbach, and J Rankin Intracellular inclusions, pathological markers in diseases caused by expanded polyglutamine tracts? J. Med. Genet., April 1, 1999; 36(4): 265 - 270. [Abstract] [Full Text] |
||||
![]() |
M. K. Perez, H. L. Paulson, S. J. Pendse, S. J. Saionz, N. M. Bonini, and R. N. Pittman Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation J. Cell Biol., December 14, 1998; 143(6): 1457 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hardy and K. Gwinn-Hardy Genetic Classification of Primary Neurodegenerative Disease Science, November 6, 1998; 282(5391): 1075 - 1079. [Abstract] [Full Text] |
||||
![]() |
M. Turmaine, A. Raza, A. Mahal, L. Mangiarini, G. P. Bates, and S. W. Davies Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease PNAS, July 5, 2000; 97(14): 8093 - 8097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Carmichael, J. Chatellier, A. Woolfson, C. Milstein, A. R. Fersht, and D. C. Rubinsztein Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease PNAS, August 15, 2000; 97(17): 9701 - 9705. [Abstract] [Full Text] [PDF] |
||||













